"Marshfield Medical Center-Rice Lake is a fully integrated medical campus that provides comprehensive hospital and medical office health care services and facilities designed to promote healing and comfort. Services at this location include: Cardiac rehabilitation Emergency care Endoscopy Health and Wellness Center Home Health Care Hospice Infusion Intensive care Joint replacement Kidney dialysis Lactation Lifeline Maternity Medical offices primary and specialty outpatient care (Rice Lake – Outpatient Services) Nutrition counseling Oncology Pacemaker services Pain management clinic Pediatric therapy Pulmonary rehabilitation Rehab Respiratory therapy Sleep studies Surgery and outpatient surgery Tobacco cessation Women's health"

During the past decade, Marshfield Medical Center-Rice Lake conducted 156 clinical trials. In the 10-year time frame, 156 clinical trials started and 96 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 49 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marshfield Medical Center-Rice Lake" #1 sponsor was "National Cancer Institute (NCI)" with 135 trials, followed by "SWOG Cancer Research Network" with 41 trials sponsored, "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 24 trials sponsored and "NRG Oncology" with 24 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshfield Medical Center-Rice Lake" #1 collaborator was "National Cancer Institute (NCI)" with 130 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Marshfield Medical Center-Rice Lake" are "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Fallopian Tube Transitional Cell Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Marshfield Medical Center-Rice Lake" in a lesser frequency.

Most popular intervention types in "Marshfield Medical Center-Rice Lake" are "Drug" (207 trials), "Other" (171 trials), "Biological" (108 trials), "Procedure" (78 trials) and "Radiation" (38 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (84 trials), "Quality-of-Life Assessment" (73 trials), "Questionnaire Administration" (42 trials), "Computed Tomography" (38 trials) and "Biospecimen Collection" (36 trials). Other intervention names were less common.

The vast majority of trials in "Marshfield Medical Center-Rice Lake" are 213 trials for "All" genders, 42 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Marshfield Medical Center-Rice Lake". undefined are not yet recruiting, 80 are recruiting, 115 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Marshfield Medical Center-Rice Lake, 6 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Marshfield Medical Center-Rice Lake, 7 "Phase 1" clinical trials were conducted, 118 "Phase 2" clinical trials and 144 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".